HER2 Support Group Forums - View Single Post - Key molecule can be used to assess prognosis of triple negative breast cancer

News · 08-21-2020, 07:03 AM

Hokkaido University scientists have shown that Interleukin-34 is a prognostic marker and drug target for Triple Negative Breast Cancer.

More...

08-21-2020, 07:03 AM	#1
News Senior Member Join Date: Oct 2007 Posts: 18,951	Key molecule can be used to assess prognosis of triple negative breast cancer Hokkaido University scientists have shown that Interleukin-34 is a prognostic marker and drug target for Triple Negative Breast Cancer. More...